Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6

Authors

SC Bain
Katherine Tuttle, Providence Medical Research CenterFollow
See Full List of Authors in Comments

Document Type

Presentation

Publication Date

6-2023

Publication Title

60th ERA Congress 2023

Keywords

washington; spokane; pmrc

Clinical Institute

Kidney & Diabetes

Department

Nephrology

Department

Endocrinology

Comments

Bain SC, Bosch-Traberg H, Cherney D, Rasmussen S, Sokareva K, Khunti K, Tuttle KR

Recommended Citation

Bain, SC; Tuttle, Katherine; and See Full List of Authors in Comments, "Kidney disease outcomes with semaglutide versus placebo across baseline KDIGO risk categories: a post-hoc analysis of SUSTAIN 6" (2023). Articles, Abstracts, and Reports. 7293.
https://digitalcommons.providence.org/publications/7293